The World Federation of Neurosurgical Societies (WFNS) Innovation & Technology Committee and Time Medical International Ventures (India), a wholly owned subsidiary of Fischer Medical Ventures, have announced a collaboration to advance global neurosurgical innovation.
This marks the first time the Committee has formally partnered with an industry participant, reflecting the growing importance of collaboration between neurosurgical leadership and advanced medical technology providers.
The collaboration will focus on cutting-edge neurosurgical technologies, advanced medical imaging, global training and knowledge-sharing initiatives to improve patient outcomes worldwide. They aim to set a new benchmark for ethical, innovation-led partnerships in global neurosurgical care.
Time Medical International Ventures has been recognised for its contributions in advanced medical imaging and neurosurgical technologies, including single-room intraoperative MRI operation suites, Exoscope and visualisation technologies, and specialised MRI solutions for brain aneurysm and ICAD screening. The collaboration is expected to create a strong platform for innovation-driven advancements in neurosurgery and neuroimaging.
Prof. Dr. Iype Cherian, Chairperson of the WFNS Innovation & Technology Committee, stated, “For the first time in the history of the WFNS Innovation Committee, we are opening our doors to the private sector. This partnership reflects our commitment to bringing together the most innovative minds and transformative technologies to advance neurosurgical care globally. Time Medical International Ventures has demonstrated exceptional capabilities in innovation and clinical technology, making them an ideal partner as we work collectively to shape the future of neurosurgery.”
He expressed confidence that the collaboration will help champion the development and global dissemination of cutting-edge neurosurgical solutions, facilitate knowledge exchange between leading neurosurgeons and industry experts, and support training and technology transfer initiatives in emerging markets.
“We believe this partnership will set a new benchmark for industry collaboration within global neurosurgical governance,” Dr. Cherian added.
Commenting on the partnership, Svetlana Rao, Director of Time Medical International Ventures (India), said, “This collaboration represents a shared vision of advancing neurosurgical excellence through innovation, technology, and global cooperation. As a wholly owned subsidiary of Fischer Medical Ventures Limited, we remain committed to supporting transformative healthcare solutions that improve accessibility, precision, and patient outcomes across diverse healthcare systems.”
The partnership underscores a shared commitment toward ethical, impactful, and innovation-led progress in neurosurgery is expected to serve as a model for future global collaborations between clinical leadership and the medical technology industry.
